Skip to main content icon/video/no-internet

DOUGLAS MELTON IS currently a leading embryonic stem cell researcher and the Thomas Dudley Cabot Professor in the Natural Sciences at Harvard University. In addition, Doug Melton is the codirec—tor of the Harvard Stem Cell Institute, chair of the Life Sciences Council at Harvard's Faculty of Arts and Sciences, and since 1994, a Howard Hughes Medical Institute Investigator. He received his bachelor's of science degree in biology, Phi Beta Kappa, from the University of Illinois, Urbana, in 1975 and a bachelor's of arts from Cambridge University in history and the philosophy of science as a Marshall Scholar. He also received his doctoral degree from Cambridge University, at Trinity College, under the supervision of J. B. Gurdon and while working in the Medical Research Council Laboratory of Molecular Biology. He is also a member of the National Academy of Sciences (since 1995), the Institute of Medicine (2001), and the American Academy of Arts and Sciences (1995).

Melton's research aims to understand how human stem cells become different types of tissues, particularly the pancreas and its insulin—producing beta cells. Melton began as a scientific researcher studying development, RNA processing, and translation in frog (Xenopus laevis) oocytes. However, in 1993, when his infant son was diagnosed with type 1 diabetes mellitus, a disease in which the insulin—producing cells of the pancreas are destroyed, Melton changed his research's direction to address the development of vertebrate organs from stem cells. His son and daughter are now in their teens, and both are affected by this disease; as diabetics, they are at risk of future blindness, organ failure, and heart disease. Melton has been quoted in an interview in the New York Times saying, “Like any parent, I asked myself, ‘What can I do?’ … I wanted my children to know I was doing everything I could for them.” An ultimate goal of his work is to make transplantable pancreatic tissue for diabetic patients by understanding how the pancreas develops and how to instruct embryonic stem cells to make pancreatic tissue.

Breakthroughs

Melton's laboratory's recent work has had a variety of major breakthroughs. In 2004 an article from his laboratory in Nature reported that preexisting beta cells of the pancreas primarily duplicate to replenish their numbers, rather than resulting from plu—ripotent stem cells differentiating. One year later, Melton's group showed that embryonic stem cells could fuse with and reprogram the transcriptional state of a somatic cell. In early 2007 another article in Nature from Melton's laboratory demonstrated that the number of cells in the pancreas progenitor cell pool limits mice pancreas size.

Using funding from the Howard Hughes Medical Institute, the Juvenile Diabetes Association, and alumni of Harvard University, Melton helped continue his stem cell research independent of federal funding after August 9, 2001, and provided a number of human embryonic stem cell lines for free to other researchers.

Honors

Melton has received many awards and honors. As a undergraduate, he was an Edmund J. James Scholar from 1975 to 1978. In 1981 he won the Max Perutz Prize and the Camille and Henry Dreyfus Award. Between 1983 and 1986, Melton was a Searle Scholar. In 1991 Melton received the George Ledlie Prize, a Harvard award given in recognition of the individual who “since the last awarding of said prize has by research, discovery or otherwise made the most valuable contribution to science, or in any way for the benefit of mankind.” That same year, he was received an American Society of Biochemistry and Molecular Biology Young Investigator Award. In 1995 he received the Richard Lounsbery Award from the National Academy of Sciences and became an honorary member of the Japanese Biochemical Society in 1996. In 2002 Melton was awarded the Eliot P. Joslin Medal.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading